MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Trazadone 150mg

Company: Teva Pharmaceutical
Approval Status: Approved May 1997
Treatment for: depression
Areas: Diabetes / Endocrinology; Psychiatry / Psychiatric

| General Information |


General Information

Trazadone 150mg tablets have been approved to manufacture and market as a treatment for depression. Teva previously received approval for 50mg and 100mg dosage strengths. Trazadone is the generic equivalent of Bristol Meyers Squibb’s Desyrel 7.




< back to top

Trazadone 150mg Drug Information

The Trazadone 150mg drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.